APX-201

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAPX-201

Drug Alias NameAPX-201

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionV-domain Ig suppressor of T-cell activation inhibitorsAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsT lymphocytes stimulants

TargetsV-domain Ig suppressor of T-cell activation

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesEpitomics Inc

China Registration ClassN/A

Develop Information

Active CompaniesEpitomics Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A